Silexion Therapeutics
SLXN----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Silexion Therapeutics(SLXN) predict that the EBIT is -2.749 M (--%), Beat estimate;the EPS is -8.5 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B--
-0.00B--
+0.00B--%
EPSExceed expectations
-8.5--
-12.9--
+4.4000--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf